BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15982684)

  • 21. [The regulation of experiments on animals--ethics, legislation and alternatives].
    Kopaladze RA
    Usp Fiziol Nauk; 1998; 29(4):74-92. PubMed ID: 9883499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alternative methods, the present and future].
    Zbinden G
    Therapie; 1990; 45(4):347-50. PubMed ID: 2399520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REACH, non-testing approaches and the urgent need for a change in mind set.
    Schaafsma G; Kroese ED; Tielemans EL; Van de Sandt JJ; Van Leeuwen CJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):70-80. PubMed ID: 19061930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A scientific and animal welfare assessment of the OECD Health Effects Test Guidelines for the safety testing of chemicals under the European Union REACH system.
    Combes R; Gaunt I; Balls M
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():77-122. PubMed ID: 16555961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated decision-tree testing strategies for developmental and reproductive toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):65-80. PubMed ID: 18333715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S.
    Becker RA; Borgert CJ; Webb S; Ansell J; Amundson S; Portier CJ; Goldberg A; Bruner LH; Rowan A; Curren RD; Stott WT
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):18-22. PubMed ID: 16876299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alternative methods to animal experimentation. Scientific and ethical problems].
    Adolphe M
    Bull Acad Natl Med; 1995 Jun; 179(6):1009-16; discussion 1116-9. PubMed ID: 8542344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Validity of alternatives to animal experimentation in biomedical research].
    Wilk W; Grune-Wolff B
    Cah Anesthesiol; 1990; 38(3):203-6. PubMed ID: 2207834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter to the editor: a regulatory view on the discussion on the role of alternative methods in the risk assessment of chemicals in the context of REACH.
    Gundert-Remy U; Bernauer U; Madle S; Oberemm A; Schulte A; Richter-Reichhelm HB
    Arch Toxicol; 2009 Jan; 83(1):9-10. PubMed ID: 19002668
    [No Abstract]   [Full Text] [Related]  

  • 31. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
    McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated decision-tree testing strategies for skin corrosion and irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():65-74. PubMed ID: 19025332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naturally occurring asbestos: a recurring public policy challenge.
    Lee RJ; Strohmeier BR; Bunker KL; Van Orden DR
    J Hazard Mater; 2008 May; 153(1-2):1-21. PubMed ID: 18180100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The ZEBET database on alternative methods to animal experiments in the Internet--a concrete contribution to the protection of animals].
    Grune B; Herrmann S; Dörendahl A; Skolik S; Behnck-Knoblau S; Box R; Spielmann H
    ALTEX; 2000; 17(3):127-33. PubMed ID: 11105194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent developments on the European ban on animal experiments for cosmetics].
    Ruhdel IW
    ALTEX; 2001; 18(1):13-6. PubMed ID: 11248844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. USDA: progress toward in vitro tests and other trends.
    Goodman SA
    Dev Biol Stand; 1996; 86():41-7. PubMed ID: 8785990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new EU chemicals policy--Discussions on details relevant for animal welfare.
    Sauer U
    ALTEX; 2002; 19 Suppl 1():26-9. PubMed ID: 12096327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposal to improve vertebrate cell cultures to establish them as substitutes for the regulatory testing of chemicals and effluents using fish.
    Schirmer K
    Toxicology; 2006 Jul; 224(3):163-83. PubMed ID: 16765501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
    Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
    Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TestSmart-HPV Program--development of an integrated approach for testing high production volume chemicals.
    Green S; Goldberg AM; Zurlo J
    Regul Toxicol Pharmacol; 2001 Apr; 33(2):105-9. PubMed ID: 11350193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.